Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing.

Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing.

Item
http://www.wikidata.org/entity/Q35752182
Nuclear survivin expression: a prognostic factor for the response to taxane-platinum chemotherapy in patients with advanced non-small cell lung cancer.A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccines.Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine.Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin.Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence.Mechanisms of tumor cell resistance to the current targeted-therapy agents.Modulation of peripheral immune responses by paclitaxel-ifosfamide-cisplatin chemotherapy in advanced non-small-cell lung cancer.Evaluation of testicular tissue of adult rats treated with cisplatin incorporated into the liposome.
P2860

Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing.

Item
http://www.wikidata.org/entity/Q35752182
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Defining the molecular signatu ...... ceptibility to T-cell killing.
@ast
Defining the molecular signatu ...... ceptibility to T-cell killing.
@en
type
label
Defining the molecular signatu ...... ceptibility to T-cell killing.
@ast
Defining the molecular signatu ...... ceptibility to T-cell killing.
@en
prefLabel
Defining the molecular signatu ...... ceptibility to T-cell killing.
@ast
Defining the molecular signatu ...... ceptibility to T-cell killing.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Defining the molecular signatu ...... sceptibility to T-cell killing
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932